Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
187.57
+1.36 (0.73%)
At close: Sep 17, 2025, 4:00 PM EDT
187.57
0.00 (0.00%)
After-hours: Sep 17, 2025, 7:00 PM EDT
BDX Revenue
Becton, Dickinson and Company had revenue of $5.51B in the quarter ending June 30, 2025, with 10.40% growth. This brings the company's revenue in the last twelve months to $21.39B, up 7.86% year-over-year. In the fiscal year ending September 30, 2024, Becton, Dickinson and Company had annual revenue of $20.18B with 4.16% growth.
Revenue (ttm)
$21.39B
Revenue Growth
+7.86%
P/S Ratio
2.51
Revenue / Employee
$289,000
Employees
74,000
Market Cap
53.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BDX News
- 12 hours ago - BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics - PRNewsWire
- 13 days ago - Ex-Dividend Reminder: Alphabet, Becton, Dickinson And Rogers - Forbes
- 14 days ago - Becton, Dickinson And Company (BDX) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 15 days ago - BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative - PRNewsWire
- 21 days ago - Best Dividend Aristocrats For September 2025 - Seeking Alpha
- 23 days ago - Best Dividend Kings: August 2025 - Seeking Alpha
- 4 weeks ago - Becton, Dickinson: Great Time To Buy This Dividend Aristocrat - Seeking Alpha
- 4 weeks ago - 11 Dividend Aristocrats With Excellent Upside Potential In The Next Year - Seeking Alpha